BOTHELL, Wash. — Cardiac Science Corporation, a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, announced that the Los Angeles County Fire Department equipped its first responder units with 425 Powerheart(R) G3 and G3 Pro(R) automated external defibrillators (AEDs).
“Like first responders everywhere, LA County Fire is a critical link in the survival chain, delivering life-saving trauma interventions immediately upon its arrival at an accident scene, or when responding to a sudden cardiac arrest,” said Battalion Chief Ed Gandara, Emergency Medical Services Section. “A shock to the heart from an external defibrillator within a few minutes of a sudden cardiac arrest is absolutely critical. We want to equip our paramedics with the right equipment to increase the likelihood of resuscitating a victim.” After thorough review, LA County Fire chose to outfit its units with Powerheart AEDs from Cardiac Science.
The Powerheart AED G3 and G3 Pro defibrillators are designed to be the most advanced and reliable defibrillation products on the market today. They meet and exceed tough clinical and environmental standards for professional fire and emergency medical services. Features on the G3 Pro include the industry’s first ECG color display in an AED, manual override, three-lead monitoring and multiple rescue capability. These products also provide the ability to download rescue data to LA County Fire’s data management system directly from the device, simplifying medical review and reporting of cardiac events.
“LA County required data connectivity from their AEDs,” said Tony Titus, vice president of marketing. “Since our Quinton(R) and Burdick(R) cardiac monitoring products connect to many Health Information and Electronic Medical Record systems using our HeartCentrix(R) technology, we extended the application to our Powerheart AEDs to meet their specific requirements.”
About Los Angeles County Fire Department
LA County Fire provides fire and EMS services to more than four million residents over 2,300 square miles in Los Angeles County, including 58 cities and towns. LA County Fire professionals include more than 2800 safety personnel, in addition to more than 700 lifeguards and numerous other support personnel. In 2006, LA County Fire first responders treated nearly 200,000 victims.
About the Powerheart AED by Cardiac Science
Having won more than 80 Powerheart patents, Cardiac Science engineers build AEDs with some of the most technologically advanced, easiest-to-use features available in AEDs today. Hospitals, police and fire departments use Powerheart AEDs to meet or exceed their demanding clinical needs. Major corporations, public agencies, airlines and airports, arenas, schools, hotels, casinos and consumers prefer Powerheart for its intuitive ease of use.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), Powerheart(R), Quinton(R), and HeartCentrix(R) brands, is headquartered in Bothell, Washington. The company, with customers in more than 100 countries worldwide, has operations in the United States (California and Wisconsin), Europe, and Asia. For information, call 425-402-2000 or visit http://www.cardiacscience.com/.
Forward-Looking Statements
This press release contains forward-looking statements including, but not limited to, those which infer that Cardiac Science Corporation’s future revenue and profits may grow as a result of sales of defibrillation products. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “intend,” anticipate,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2006. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
Contact
Mike Matysik, Senior Vice President and CFO of Cardiac Science Corporation, +1-425-402-2009;
or investors, Douglas Sherk or Jenifer Kirtland, +1-415-896-6820;
or media, Steve DiMattia, +1-646-201-5445, all of EVC Group, Inc., for Cardiac Science Corporation
Web site: http://www.cardiacscience.com/